{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T07:02:14Z","timestamp":1789974134821,"version":"4.0.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["chestpulmonary.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST Pulmonary"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.chpulm.2025.100214","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T19:45:50Z","timestamp":1759347950000},"page":"100214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Real-World Experience of Midodrine in Hospital Setting in Pulmonary Arterial Hypertension"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0027-2239","authenticated-orcid":false,"given":"Noah","family":"Giese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8984-8205","authenticated-orcid":false,"given":"Zeenat","family":"Safdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anisha","family":"Mulumudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Momin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson Villasmil","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duc T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward A.","family":"Graviss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.chpulm.2025.100214_bib1","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/CIRCULATIONAHA.116.022362","article-title":"Systemic consequences of pulmonary hypertension and right-sided heart failure","volume":"141","author":"Rosenkranz","year":"2020","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.chpulm.2025.100214_bib2","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1164\/rccm.201903-0656CI","article-title":"Beyond the lungs: systemic manifestations of pulmonary arterial hypertension","volume":"201","author":"Nickel","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chpulm.2025.100214_bib3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12931-022-02296-z","article-title":"Tolerability, safety and survival in patients with severe pulmonary arterial hypertension treated with intravenous epoprostenol (Veletri\u00ae): a prospective, 6-months, open label, observational, non-interventional study","volume":"24","author":"Degering","year":"2023","journal-title":"Respir Res"},{"issue":"38","key":"10.1016\/j.chpulm.2025.100214_bib5","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.chpulm.2025.100214_bib6","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrcardio.2017.84","article-title":"Epidemiology and treatment of pulmonary arterial hypertension","volume":"14","author":"Lau","year":"2017","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"10.1016\/j.chpulm.2025.100214_bib7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12931-021-01827-4","article-title":"In-vitro and in-vivo comparisons of high versus low concentrations of inhaled epoprostenol to adult intubated patients","volume":"22","author":"Li","year":"2021","journal-title":"Respir Res"},{"issue":"11","key":"10.1016\/j.chpulm.2025.100214_bib8","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.healun.2013.08.010","article-title":"Treatment of patients with pulmonary arterial hypertension at the time of death or deterioration to functional class IV: Insights from the REVEAL Registry","volume":"32","author":"Farber","year":"2013","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"10.1016\/j.chpulm.2025.100214_bib9","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/hep.510280407","article-title":"Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites","volume":"28","author":"Angeli","year":"1998","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.chpulm.2025.100214_bib10","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/MCG.0b013e318188947c","article-title":"Combination treatment with octreotide, midodrine, and albumin improves survival in patients with type 1 and type 2 hepatorenal syndrome","volume":"43","author":"Skagen","year":"2009","journal-title":"J Clin Gastroenterol"},{"issue":"11","key":"10.1016\/j.chpulm.2025.100214_bib11","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1007\/s11606-013-2520-3","article-title":"Midodrine for orthostatic hypotension: a systematic review and meta-analysis of clinical trials","volume":"28","author":"Parsaik","year":"2013","journal-title":"J Gen Intern Med"},{"issue":"4","key":"10.1016\/j.chpulm.2025.100214_bib12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10286-016-0363-9","article-title":"Clinical benefit of midodrine hydrochloride in symptomatic orthostatic hypotension: a phase 4, double-blind, placebo-controlled, randomized, tilt-table study","volume":"26","author":"Smith","year":"2016","journal-title":"Clin Auton Res"},{"issue":"6","key":"10.1016\/j.chpulm.2025.100214_bib13","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1378\/chest.115.6.1708","article-title":"Alpha1-adrenergic hypothesis for pulmonary hypertension","volume":"115","author":"Salvi","year":"1999","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.chpulm.2025.100214_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/ajhp\/zxy001","article-title":"Midodrine treatment in a patient with treprostinil-induced hypotension receiving hemodialysis","volume":"76","author":"Drambarean","year":"2019","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.chpulm.2025.100214_bib15","article-title":"Midodrine as a novel tool to optimize pulmonary arterial hypertension therapies","volume":"205","author":"Rao","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chpulm.2025.100214_bib16","article-title":"Longitudinal use of midodrine to optimize pulmonary hypertension therapies","volume":"207","author":"Safdar","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.chpulm.2025.100214_bib17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.14797\/mdcvj.1308","article-title":"Pulmonary hypertension in women","volume":"20","author":"Park","year":"2024","journal-title":"Methodist Debakey Cardiovasc J"},{"issue":"3","key":"10.1016\/j.chpulm.2025.100214_bib18","first-page":"320","article-title":"Statistical evaluation of absolute change versus responder analysis in clinical trials","volume":"1","author":"Wang","year":"2022","journal-title":"Acta Mater Med"},{"issue":"10","key":"10.1016\/j.chpulm.2025.100214_bib19","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1007\/s00134-020-06216-x","article-title":"Effect of midodrine versus placebo on time to vasopressor discontinuation in patients with persistent hypotension in the intensive care unit (MIDAS): an international randomised clinical trial","volume":"46","author":"Santer","year":"2020","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.chpulm.2025.100214_bib20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12871-017-0339-x","article-title":"Midodrine as adjunctive support for treatment of refractory hypotension in the intensive care unit: a multicenter, randomized, placebo controlled trial (the MIDAS trial)","volume":"17","author":"Anstey","year":"2017","journal-title":"BMC Anesthesiol"},{"issue":"1","key":"10.1016\/j.chpulm.2025.100214_bib21","first-page":"003246","article-title":"Use of midodrine in heart failure: two case reports and a review of the literature","volume":"9","author":"Hajjiah","year":"2022","journal-title":"Eur J Case Rep Intern Med"},{"key":"10.1016\/j.chpulm.2025.100214_bib22","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejim.2022.08.031","article-title":"Might midodrine be useful in patients with decompensated and worsening chronic heart failure?","volume":"105","author":"Fern\u00e1ndez-Fern\u00e1ndez","year":"2022","journal-title":"Eur J Intern Med"},{"issue":"7","key":"10.1016\/j.chpulm.2025.100214_bib23","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/lt.24467","article-title":"Novel role of midodrine in pulmonary hypertension in liver transplant candidates","volume":"22","author":"Rajaram","year":"2016","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.chpulm.2025.100214_bib24","first-page":"132","article-title":"Beneficial effect of midodrine in hypotensive cirrhotic patients with refractory ascites","volume":"7","author":"Sourianarayanane","year":"2011","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"16","key":"10.1016\/j.chpulm.2025.100214_bib27","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJMoa2213558","article-title":"Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension","volume":"388","author":"Hoeper","year":"2023","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.chpulm.2025.100214_bib28","doi-asserted-by":"crossref","first-page":"e12016","DOI":"10.1002\/pul2.12016","article-title":"Real-world dosing characteristics and utilization of parenteral treprostinil in the outpatient setting","volume":"12","author":"Balasubramanian","year":"2022","journal-title":"Pulm Circ"},{"key":"10.1016\/j.chpulm.2025.100214_bib29","article-title":"Midodrine to optimize heart failure therapy in patients with concurrent hypotension","volume":"10","author":"Shiu","year":"2022","journal-title":"SAGE Open Med Case Rep"}],"container-title":["CHEST Pulmonary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949789225000819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949789225000819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:23:57Z","timestamp":1789971837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949789225000819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2949789225000819"],"URL":"https:\/\/doi.org\/10.1016\/j.chpulm.2025.100214","relation":{},"ISSN":["2949-7892"],"issn-type":[{"value":"2949-7892","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-World Experience of Midodrine in Hospital Setting in Pulmonary Arterial Hypertension","name":"articletitle","label":"Article Title"},{"value":"CHEST Pulmonary","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chpulm.2025.100214","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc under license from the American College of Chest Physicians.","name":"copyright","label":"Copyright"}],"article-number":"100214"}}